Form 8-K · Current Report · Filed 2026-04-03
Agilent Technologies Announces Departure of Chief Legal Officer
On March 31, 2026, Agilent Technologies, Inc.
- Filer
- Agilent Technologies Inc. A · NYSE
- Filed
- Accession
- 0001193125-26-142101
- CIK
- 0001090872
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Details
announced that Bret DiMarco, Senior Vice President, Chief Legal Officer, and Secretary, will resign from his roles upon the earlier of the start date of a new Chief Legal Officer or September 30, 2026. He will continue as a Special Advisor until December 1, 2026, and will receive a base salary, health and welfare benefits, and equity vesting, but no additional equity grants or annual bonus. After his service as Special Advisor, he will receive a lump sum payment.
Items reported
Reported Item
Market reaction
Close before filing
$115.48
Next session
-0.6%
Since filing
+19.8%
Latest close
$138.37
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from A reporting the same item, with the next session's move:
Insider tape
Within 45 days of this filing, A insiders reported 1 Form 4 transaction — net selling of $43K.
About Agilent Technologies Inc.
Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.
Never miss another A filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.